Much of the existing work has been emphasized on cure detections and regression techniques. In contrast, this project focuses on the hypothesis testing in the presence of a cure fraction. Specifically, our interest lies in detecting whether there exists survival differences among noncured patients between treatment arms. For this purpose, we investigate the use of a modified Crame´r-von Mises statistic for two-sample survival comparisons within the framework of cure models. Such a test has been studied by Tamura et al., (Statistics in Medicine 19, 2000, 2169 using bootstrap procedure. We will focus on developing asymptotic theory and convergent algorithms in this paper. We show that the limiting distributions of the Crame´r-von Mises statistic under the null hypothesis can be represented by stochastic integrals and a weighted noncentral chi-squares. Both representations lead to concrete numerical schemes for computing the limiting distributions. The algorithms can be easily implemented for data analysis and significantly reduce computing time compared to the bootstrap approach. For illustrative purposes, we apply the proposed test to a published clinical trial.
Introduction
In cancer trials the idea of 'cure from cancer' is that the disease would be completely eliminated so that it never recurs, and the patient's lifespan is the same as that of someone who has never suffered cancer. Treatments are typically developed to increase patients' chances of being cured, but considerable interest has also been given to pursue treatments that prolong survival among noncured patients as well. Because the study population is essentially an unobservable mixture of patients deemed curable and noncurable, evaluation of treatment effects in such a scenario is often complicated. A recently published study is presented below as an illustrative example.
Between 1992 and 1999, a phase III clinical trial was conducted by Adelstein et al. (2003) of the Eastern Cooperative Oncology Group (ECOG) to evaluate treatment effects in patients with unrespectable head and neck cancer. Patients were randomized among the following. treatment arms: a standard single daily fractionated radiotherapy (control arm), and a split course of single daily fractionated radiotherapy and chemotherapy (experimental arm) One primary endpoint was whether these treatments had survival benefit in terms of preventing death from head and neck cancer. In this trial, a number of long term survivors have been observed. But, in addition to the comparison of the cure rates, the investigators were also, interested in evaluating the treatment effect in terms of survival among patients who were not cured.
The concept of cure brings new clinical interests as well as statistical challenges. For instance, clinical objectives are not only focused on the comparison of unconditional distributions of the time to a medical event of interest (e.g. death), but also on that of the conditional distributions within noncured patients (e.g. Berkson and Gage, 1952; Farewell, 1982; Green-house and Wolfe, 1984, Gray and Tsiatis, 1989; Laska and Meisner, 1992) . Meanwhile, other characteristic problems in survival analysis need to be addressed. For example, random accrual and patients' dropout or loss to follow up are to be modeled through random right censoring processes. Several authors (e.g. Kuk and Chen, 1992; Peng and Dear, 2000; Sy and Taylor, 2000) have proposed using semiparametric cure models to analyze such data, with emphasis placed on regression modeling. A complete review of the statistical methods using censored failure time to determine the presence of a cure fraction can be seen in Zhou (1992, 1993) .
In this article, we will take a different perspective by focusing on the characterization of the conditional distribution among noncured individuals. That is, we are interested in studying the distribution of the time-to-event variables given the event (e.g. disease-related death) will occur before a clinically meaningful terminal time s. Explanations of these types of models from medical viewpoints, together with some available statistical methods (e.g. likelihood ratio tests and rank tests) can be found in, for example, Laska and Meisner (1992) and Gray and Tsiatis (1989) , and the likelihood ratio test has been used to analyze a clinical trial (Laska et al. 1991) .
Indeed, the past two decades has seen a rapid development of statistical tools for detecting survival differences in clinical trials, but log-rank type tests, mast powerful under proportional hazards alternatives, are routinely performed by practitioners in the absence of cure fractions. Schumacher (1984) , however, demonstrated via simulation that Crame´r-von Mises statistics have decent power under proportional hazards alternatives and are superior to log-rank tests in other cases. A Crame´r-von Mises type statistic was proposed by Tamura et al. (2000) for a two-sample survival comparison within the framework of cure models, and inference was drawn via bootstrap simulations. On the other hand, in the absence of cure fractions the asymptotic theory of the Crame´r-Non Mises type statistic for one-sample comparisons under particular parametric models has been intensively investigated by Koziol and Green (1976) (with censoring) and Stute (1997) (without censoring) This article investigates the use of the Crame´r-von Mises statistic for two-sample comparisons in the presence of censoring and cure fractions. Moreover, we develop the asymptotic theory in a more general framework: unlike in Koziol and Green (1976) , our procedure does not require the specification of the censoring distributions. We also give concrete numerical algorithms for practical applications without resorting to resampling schemes. Though both deal with survival comparisons for cure models, our motivation differs from that of Gray and Tsiatis (1989) in that their main interest was in testing differences in cure rates, while we are primarily interested in testing differences in survival among noncured patients. In contrast to Tamura et al. (2000) , we further the asymptotic theory: not only do we give two characterizations of the limit distribution in detail (one of which appeared sketchily in Tamura et a1. (2000) as well), but also we construct practically usable algorithms based on them. As our simulation results (in Section 6) indicate, the proposed algorithms significantly reduce computing time compared to the bootstrap procedure. In addition, the involved techniques may have applications elsewhere, for example, numerically performing Loe`ve principle component decomposition of a complex stochastic process.
The rest of the article is structured as follows. We state a general cure model in Section 2, and formulate a two-sample comparison hypothesis in Section 3. We introduce in Section 4 a modified version of Crame´r-von Mises statistic, and derive its large sample properties, and give in Section 5 two numerical simulation schemes for constructing the limiting distributions of the Crame´r-Von Mises statistics. We conduct simulation studies in Section 6 to examine the finite sample performance of the proposed two algorithms, and illustrate the use of the Crame´r-von Mses statistics by analyzing a published clinical trial in head and neck cancer in Section 7. We conclude this article with general discussion in Section 8. In the Appendix, we give the technical proofs to the main theorems, and include a convergence result on stochastic integrals, which has largely facilitated our proofs.
Throughout this article, F(t)=P(T£ t) denotes the distribution for a nonnegative random variable T, X n Þ X means random variables X n converge to X in distribution, X n fi X means the convergence is in probability, X ¼ D Y means random variables X and Y are equally distributed, and for any real function g(AE), g(¥)) means lim x!1;x6 ¼1 gðxÞ if the limit exists.
A General Cure Model
Let T be a nonnegative random variable of interest, for example, the time from the start of treatment to disease-related death in motivating example. We assume that its distribution on the extended real line [0, +¥] , where +¥ is identified to be a single point, is given by
where f ! 0; R 1 0 fðtÞdt ¼ 1; qðor pÞ is the cure (or noncure) proportion, and for any a 2 ½0; þ1; d a ðÁÞ is a counting measure with a point mass on a. This is equivalent to saying that T follows a mixed distribution with a dominating measure consisting of a Lebesgue measure and a singular point mass placed at +¥. In reality it would be a reasonable assumption that the probability density f, corresponding to the noncure proportion of T, have a compact support [0,s]Ì[0,¥), and
For instance, if a disease-related death did not occur to a patient after a long time of observation, say roughly; 5 years in a head and neck cancer clinical trial, it would be 'safe' to predict that patient would not die from this caner. Similar formulations for this type of cure models can be found in Zhou (1992, 1993) and Peng and Dear (2000) , among others. We can either directly identify the s, the clinically meaningful terminal time, with available medical knowledge or estimate it from empirical data. Specifically, denote byF the Kaplan-Meier estimate for the distribution function F and note that (1) is equal to
then s can be consistently estimated bŷ
which is the turning point after which the estimated distribution curve becomes plateau, and is indeed the largest uncensored failure time (Maller and Zhou, 1992) . Elementary probabilistic arguments immediately imply thatŝ s almost surely. Hence, by (3) and the monotonicity ofF, FðŝÞ ¼FðsÞ ¼Fð1ÀÞ almost surely.
Both (1) and (3) indicate that s can be identified and estimated from F, as a function of f and p. Additionally, since estimating and testing f or p is of major interest to us, we will focus only on these two parameters (and not s) in this article; a detailed discussion on s and its estimation can be found in Maller and Zhou (1992) .
Two-Sample Comparison of Cure Models
Large-scale clinical trials, for example, phase III trials, are often designed to detect survival benefits among competitive regimen, and two-sample comparisons are frequently utilized. In what follows, we study the Crame´r-von Mises type statistic for comparing two treatments in a clinical trial.
The notation below is similar to that in the general cure model, except that we use an additional subscript i to indicate treatment. Specifically, we denote the time-to-event variables by T ij $ F i ; i ¼ 1; 2; j ¼ 1; . . . ; n i , where, for example, i=1 corresponds to the control arm and i=2 to the experimental arm, F i s are distribution functions, and j refers to the j-th patient in his respective treatment arm; we also assume the nonnegative censoring times U ij $ G i where G i s are distribution functions. We further assume that the fT ij ; U ij : i ¼ 1; 2; j ¼ 1; . . . ; n i g are all independent. Because of censoring, we observe V ij ¼ T ij^Uij and d ij ¼ IðT ij U ij Þ. If our interest was in estimating and comparing the F i ,(i=1, 2), we would use standard methods for right censored data, such as the Kaplan-Meier estimators or the log-rank type statistics. However, the distributions of more direct interest are two these conditional distributions F Ã i ðtÞ ¼ PðT ij tjT ij < 1Þ; i ¼ 1; 2. To explore how to compare these conditional distributions, first let
For a two-sample comparison, the statistical test is formulated as
We assume both f i s have compact support s i infft ! 0 : sup s!t f i ðsÞ ¼ 0g < 1, and denote s ¼ maxfs 1 ; s 2 g such that [0,s] covers the supports of both f 1 and f 2 . Moreover, we assume that
so that s can be observed with a positive probability in both treatment arms. As is the case without cure fractions, if it is reasonable to believe that F Ã 1 ðtÞ F Ã 2 ðtÞ (or vice versa), H 1 should be replaced by a one-sided hypothesis. Furthermore, if the proportional hazard assumption is approximately satisfied, a log-rank type statistic, powerful in detecting the stochastic dominance, should perform better than its Crame´r-von Mises counterpart. However, without such a proportionality assumption, the Crame´r-von Mises type statistic, which is particularly useful in detecting the deviation of two distributions, is more appropriate (see, e.g. Schumacher, 1984) .
Crame´r-von Mises Statistic and its Asymptotics Properties
Let n 1 and n 2 be the sample size of two arms, respectively, and n=n 1 +n 2 . Following Laska and Meisner (1992) , for each i=1, 2, we derive nonparametric maximum likelihood estimate of F Ã i based on the observed data ðV ij ; d ij Þ; j ¼ 1; . . . ; n; aŝ F Ã i ðtÞ ¼p À1 iF i ðtÞ; whereF i ðtÞ is the usual Kaplan-Meier estimator for the F i andp i ¼F i ð1ÀÞ is the consistent estimate for p i , the .estimated noncure fraction in the i-th arm (see, Maller and Zhou, 1992) .
Denote the pooled conditional distribution bŷ
To test H 0 in (4), we define a modified version of Crame´r-von Mises statistic to measure the discrepancy between the two empirical distributionsF Ã 1 ðÁÞ andF Ã 2 ðÁÞ as follows
The following theorem gives the asymptotic distribution of W n , under
THEOREM 1 Assume that n 1 /n fi c. Then under the null hypothesis, the Crame´r -von Mises statistic,
where the Gaussian process G is (distributionally) uniquely defined by 
Remark. The validity of this theorem requires, c i (t),i=1, 2, the changes of time in the Gaussian processes, be finite over [0, ¥). For each i=1, 2, because c i (t) is nondecreasing we only need to show the finiteness of c i (¥ )). In fact, if s<¥ as assumed and under (5),
The proof relies on large sample results of the Kaplan-Meier product limit estimator and can be found in Tamura et al. (2000) . Asymptotic results of the Kaplan-Meier estimates have been proved by Breslow and Crowley (1974) , Gill (1984) , and Fleming and Harrington (1991) in various degrees of generalization. We note in this theorem the null distribution F* is left unspecified, but it can be replaced by its empirical estimateF Ã pool when approximating the distribution of X under the null hypothesis; see Algorithm 1 and the associated large sample result (Theorem 4) in Section 5.
For gaining additional insight into the limiting distribution of the Crame´r-von Mises statistics under H 0 , we consider a Loe`ve type expansion in terms of principal components. Specifically, we represent the X in Theorem 1 as a mixture of noncentral v 2 , which would facilitate numerical realizations. Similar results in the context of noncensored data or censored data without cured fraction are available, see for example Durbin et al. (1972 Durbin et al. ( , 1975 and Chapter 5 of Shorack and Wellner (1986) . With some modifications, the arguments in these references would apply in the new context of cure models for establisling the existence of such decompositions. However, as is frequently the case in practice, the difficulty for making use of these results lies in the computation of the associated eigenvalues (e.g. the k k s below). By focusing on some special classes of parameterized distributions (of both survival and censoring times), the aforementioned references have obtained closed-form eigenvalues. But, in more general scenarios (e.g. censored data with a cure fraction as we have) we would not expect such explicit formulae to exist. Therefore, we approach this issue from a numerical perspective by deriving the kernel function for the principal component decomposition in more general situations, where the distribution functions for both survival and censoring times are left unspecified. Based on this decomposition, a numerical algorithm is developed in Section 5 for computing the associated eigenvalues.
By exploiting the independence of W 1 (AE) and W 2 (AE), we can compute the covariance function K(s, t) of the Gaussian process G(AE 
The result is summarized in the following theorem, whose proof can be found in the Appendix.
THEOREM 2 The distribution for the limiting random variable X in Theorem 1 can be represented as the following noncentral v Again, without loss of generality, we may assume the k k are decreasing in k to zero.
After identifying elements by their equivalence classes, (L
, (AE,AE)). In practice, unless some strong parametric assumptions are made, numerical, computation of the k k s will typically involve in matrix approximation of the, integral operator T, which has F* as an integrator. A direct discretization for T on interval [0, s] with uniform mesh size may cause numerical instability. Through a change of variables, we can convert the eigenvalue problem for T in the space (L 2 ([0, s]), (AE,AE)) to an equivalent eigenvalue problem for operator T in the Hilbert space on the unit interval L 2 ð½0; 1Þ; hÁ; Ái À Á , wherein the inner product is hf;gi ¼ R 1 0f ðrÞgðrÞdr forf;g 2 L 2 ð½0; 1Þ. We give in the Appendix the explicit form ofT and the justification that these two operators have the same set of eigenvalues on each individual Hilbert space. Hence, for numerical stability, our numerical scheme (outlined in Section 5) will be based on the transformed operatorT. In particular, assuming that F* is strictly increasing and absolutely continuous and letting
ðs;tÞgðsÞds for anyg 2 L 2 ð½0; 1Þ, wherek is as defined in (14), one may show in the Appendix that the k k , are also eigenvalues for the integral operatorT. The k k 's can be computed more conveniently from operatorT than from operator T directly.
The representation of X in (8) implies that the shape of distribution should be similar to that of the v 2 . We confirm this by a numerical approximation in our data example later. Koziol and Green (1976) 
Àð1þbÞ and the covariance function K(s, t) has a simple form: Kðs; tÞ ¼ 4ð1 À sÞð1 À tÞf1 À ð1 À s^tÞ À1þbÞ g . They computed the k i explicitly and gave some useful reference tables.
We will develop an approximation algorithm (Algorithm 2 in Section 5) to calculate these eigenvalues for more general and practical settings, where the null distribution F * and the censoring distributions G i are unspecified, and, hence, functions such as p i (s) and c i (s) in the limiting distribution are unknown. In particular, we consistently estimate these unknown quantities bŷ
IðV ij <sÞ; ð9Þ
for i=1, 2 and use them to replace p i , c i in the kernels K andk. We justify the use of (10) and (11) with the following theorem, whose proof is given in the Appendix.
THEOREM 3ĉ i consistently estimates c i . That is,ĉ i ! c i in probability on D[0, s] and this convergence is in conjunction with that ofp i to p i andF i ðtÞ to F i (t).
Numerical Approximation/Simulation Schemes
In this section we develop two 'data driven' numerical schemes to construct random variables that approximate the limiting distribution of the Crame´r-von Mises statistics. We start with estimating s maxfs 1 ; s 2 g byŝ ¼ maxfŝ 1 ;ŝ 2 g, wherê s i ¼ infft ! 0 :F i ðtÞ ¼F i ð1ÀÞg. We first present a numerical algorithm based on the stochastic integral representation theorem (Theorem 1) (see also Remark 2 of Tamura et al. (2000) , followed by a numerical scheme based on the principal decomposition theorem (Theorem 2). The associated limit theorems are also provided. Note that m is the size of the approximation scheme and n is the size of the real clinical trial dataset. Since every integral appearing in the above scheme has a piece-wise constant integrand, these integrals are effectively finite summations. In practice, we shall repeatedly apply this algorithm to obtain a series of independent realizations of X m,n in order to approximate the asymptotic distribution. Indeed, the following theorem, proved in the Appendix, shows the convergence in distribution of X m,n to the desired limit.
THEOREM 4 Under the conditions stated in Theorem 1, the X m,n defined above satisfies X m,n Þ X as m, n fi ¥, where X is the limiting random variable in Theorem 1.
Algorithm 2. An approximation scheme based on Theorem 2
In this approximation scheme, we again use m to denote the size of the approximation scheme and n the sample size of the dataset. The larger these parameters, the better for the approximant X m,n to approach the limiting X. 
Simulation Studies
Simulations were performed to examine the finite sample performance of the proposed test. Our main objectives are three folds, namely, assessment of the level of the test under varying sample sizes and degree of censoring, evaluation of the power of the test under the same varying scenarios, and comparison of our two proposed asymptotical distribution-based algorithms with the bootstrap procedure adopted by Tamura et al. (2000) .
We considered a similar simulation setup utilized by Tamura et al. (2000) . Specifically, we set the noncure proportion p 1 =0.6 in treatment group 1 (for example, the control arm) and generated the survival times for the noncured patients in this arm by the truncated Weibull distribution
where we set k=20 and a=2. This survival distribution would yield a median time to death of 16.6 time units with 90% of events occurring within 30 time units among noncured patients. On the other hand, we simulated the survival times for the noncured patients in treatment group 2 (e.g. the experiment arm) by
where b=1 corresponds to the null hypothesis and b 6 ¼ 1 corresponds to an alternative hypothesis. In our simulations we set b=1 when estimating the level of the test and varied b to be 1.5, 2 and 2.5 when evaluating the power of the test under various alternative hypotheses. Two different proportions of noncure patients in Arm B, p 2 , were considered in the simulations. We first let p 2 =0.6, which was equal to its counterpart in Arm A. In the second case we set p 2 =0.9, much higher than its counterpart in Arm B. The censoring times in both arms were independently simulated by a uniform distribution on [0, c], with c=60 inducing approximately 50% censoring prior to time 43 and c=80 inducing approximately 35% censoring prior to time 43. At the opposite extreme, we also considered the case of no censoring prior to time 43. Same levels of censoring were adopted by Tamura et al. (2000) . Finally, we considered an equal sample size of 100 per treatment group, which is typical in a two-sample clinical trial. Table 1 lists the estimates of level and power of test under various conditions, all of which were based on 1000 data realizations. More specifically, for each simulated data set, the empirical P-values were computed based on the asymptotic distributions approximated by Algorithms 1 and 2, respectively, and were later dichotomized by whether they fell below 0.05. When applying Algorithms 1 and 2, we chose the mesh size m=40 and generated 1000 realized values of 'X m,n ' to approximate the desired asymptotic distribution. We set =0.001 when using Algorithm 2. All programming was conducted in the environment of R and each entry in the table took approximately 2 h on a mainframe computer.
Based on these simulation results we observed that the size of the test ranged 0.048-0.051 for no censoring, 0.060-0.063 for moderate censoring, and 0.075-0.089 for high censoring, indicating that the test is slightly liberal if censoring is moderate or less and is more considerably 'anticonservative' if censoring is high. Same observations have been documented for the bootstrap procedure by Tamura et al. (2000) . We also noticed, as expected, that the power of the test increased rapidly as b increased from 1.5 to 2.5 and the power decreased as the amount of censoring increased. In particular, the powers obtained by the large sample approximation were slightly better than the powers obtained by the bootstrap procedure reported in Table 2 of Tamura et al. (2000) . Last we noted that Algorithms 1 and 2 yielded nearly identical sizes and powers. The sample size is 100 per treatment group. * Adopted from Table 2 in Tamura et al. (2000) . 
A Data Example
We applied the Crame´r-von Mises statistic to analyze the cancer clinical trial described previously in Section 1. Originally there were three treatment arms in this study. For simplicity, we only considered the comparison of disease-specific survival between two treatment arms in this clinical trial. In particular, the diseasespecific survival was measured for a total of 184 patients, 95 in the control arm and 89 in the experimental arm. Disease-specific survival is defined as the time from the start of treatment to the death caused by the disease. Patients dying from any other causes would be regarded as being censored at the death dates (see Adelstein et al., 2003) . The top panel of Figure 1 gives the comparison in disease-specific survival by treatment among all these 184 patients, including those who were cured and noncured, while the bottom panel shows the conditional time to disease-specific death among noncured patients.
We estimated from the data that the cured patients were those who had survived from head and neck cancer for more than 4.2 years, i.e.ŝ ¼ 4:2. Using the Kaplan-Meier estimate, we also estimated that the cure rate in the control arm wasq 1 ¼ 1 ÀF 1 ð1ÀÞ ¼ 0:25 with a 95% confidence interval (0.13, 0.37), while the cure rate in the experimental arm wasq 2 ¼ 1 ÀF 2 ð1ÀÞ ¼ 0:41 with a 95% interval (0.29, 0.53). The Wald test for equal cure rates between the two arms, i.e. H 0 : q 1 =q 2 , is marginally significant (P-value=0.056) , favoring the experimental arm. However, our interest was whether the distribution of disease-specific survival differs between the two treatment arms among noncured patients. We applied the two-sample Crame´r-von Mises statistic to test the null hypothesis that the two treatment arms have the same survival function among the noncured patients. We calculated the limiting distribution of the Crame´r-von Mises statistic under the null hypothesis by exploiting the numerical algorithms (Algorithms 1 and 2), where we set m=40 and n=184. The resulting density curves of the limit distribution obtained by both algorithms are displayed in Figure 2 . The two curves overlap for the most part and resemble a v 2 distribution. The estimated quantiles of the distributions by these two algorithms are listed in Table 2 and the leading eigenvalues of the linear operator in Algorithm 2 are tabulated in Table 3 . Based on (4), the resulting test statistic is 1.16 with a P-value of 0.356 according to the limiting distribution obtained by Algorithm 1 and 0.362 by Algorithm 2, indicating there is no strong evidence for a significant difference in disease-specific survival between the two treatment arms among the noncured patients, though the cure rate in the treatment arm is marginally superior to that in the control arm. 
Discussion
In this article, we have developed large sample results and given concrete numerical schemes for implementing a modified Crame´r-Von Mises statistic for two-sample comparisons of conditional survival curves in the presence of cure fractions. We second Tamura et al.'s (2000) opinion that the cure model is a proper model which separates the survival information into the proportion of the cured population, and the time to event conditional on being noncured patients. Both parts of information are important when evaluating treatment effects in clinical trials. Our motivation stems from comparisons of conditional survival curves, given that the tests of cure rates have been well documented in statistical literature (e.g. Gray and Tsiatis, 1989) . Our estimators and numerical schemes can be easily implemented and are fully nonparametric, which is in contrast to the statistics proposed by Koziol and Green (1976) for one-sample comparisons in the absence of cure fractions and under very specific parametric models of censorship. On the other hand, as opposed to the bootstrap-based inferential methods proposed by Tamura et al. (2000) , our work directly employs large sample results and does not require any complicated resampling schemes in data analysis, thereby significantly reducing the computational burden.
Future research is needed for studying the behavior of the proposed Crame´r-von Mises statistics under the alternative hypothesis, which might facilitate the design of a comparative clinical trial in a cure rate model. This will also enable one to compare the efficiency between the Crame´r-von Mises statistics and other commonly used statistics in survival problems (e.g. log-rank tests), under a variety of alternatives.
Related Splus or R programs for computing the proposed Crame´r-von Mises test statistic and its distribution under the null hypothesis are available upon request.
Appendix: Technical Details

A Convergence Theorem on Stochastic Integrals
The following is extracted from Theorem 2.2 in Kurtz and Protter (1991) , of which we have made repeated usage in our proofs.
THEOREM 6 For each n, let (X n , Y n ) be an fF n t g-adapted process with paths in D R 2 ½0; s. Let Y n =M n +A n , where M n (t) is an fF n t g-martingale and A n (t) be a process with finite variation. Suppose for each t,
where T t (A n ) denotes the total variation of A n up to time t and [M](t) denotes the quadratic (or called optional) variation process for a local martingale M(AE) (see, e.g. Andersen et al., 1993, p. 69) . Suppose (X n , Y n )Þ (X,Y) in the Skorohod topology on D R 2 ½0; T, then Y is a semimartingale with respect to a filtration to which (X, Y) ar adapted and X n ðtÞ; Y n ðtÞ;
XðtÞ; YðtÞ;
in the Skorohod topology. If (X n , Y n ) fi (X,Y) in probability, then (13) also converges in probability.
Proof of Theorem 2 From (7), 0 Kðs; tÞ ¼ Kðt; sÞ sup 0 s;t s Kðs; tÞ < 1. Hence, T is self-adjoint by the symmetry of K; T is positive since it maps nonnegative functions to nonnegative functions; T is compact because K is square integrable. Specifically, R s 0 R s 0 K 2 ðs; tÞFðdsÞFðdtÞ < 1 (in fact, K is even bounded). Therefore, T maps a set of uniformly bounded sequence of functions to a compact sequence of functions in the Hilbert space (Dunford and Schwartz, 1958) . Hence, spectrum theory for linear compact operators implies that Proof of Theorem 3 The Glivenko-Cantelli theorem implies that the empirical distributionp i ðsÞ ! PðV ij ! sÞ uniformly on [0, s] and this convergence is joint with the convergence in probability ofF i to F i . Thus, a direct application of Theorem 6 yields the result. h
Proof of Theorem 4 Joint with the convergence in probability (in the Skorohod topology) ofp i ! p i andF Ã pool ! F Ã , and because c i is continuous, then W m;n i ðtÞ ) W i fc i ðtÞg: This result follows from the martingale central limit theorem. Therefore, jointly we have G m,n (t)Þ G(t). Note thatF Ã pool ðtÞ satisfies assumption (12). Applying Theorem 6, X m,n Þ X. h
Justification of T andT Having Same Eigenvalues in Section 3
For simplicity, we assume that f(t)>0 whenever t2 [0,s] . Therefore, F * is strictly increasing and absolutely continuous on [0,s] . Define a one-to-one correspondence For any fixed n, b Kðs;tÞ is a bounded piece-wise constant function with finite discontinuities, so the first term in (15) Thus lim m;n!þ1 k~m ÀTk ¼ 0 in probability. The desired result then follows from Theorem 4.10 in Chapter 5 of Kato (1980) . h
